These results suggest that MAPK (Erk-1/2 and JNK) and transcription factors (Egr-1, AP-1, and NF-κB) activated by LPA upregulated RON, in turn leading to an increase in bladder cancer cell invasiveness. The gene discussed is FOS; the disease is urinary bladder cancer.